miR-184 reduced glioma growth and TNFAIP2 expression
in the mice model. A. shows the T2-weighted MRI imaging of subcutaneous tumor growth at days 25 and 35 in U87-miR-184 and U87-Negative nude mice (red arrows indicate tumors). B.-D. show that miR-184 reduced glioma growth in the subcutaneous glioma nude mice model. E. shows the representative H&E staining, which revealed that miR-184 reduced glioma growth in the encephalic glioma nude mice model. F. shows that miR-184 reduced TNFAIP2 and ki-67 expression in an in vivo mice model. Data are shown as mean + s.d. (n = 3); *indicates P-value <0.05, **indicates P-value <0.01.